Nolotil (Metamizole Magnesium)

Metamizole works by inhibiting cyclooxygenase enzymes, which reduces the synthesis of prostaglandins. Lower prostaglandin levels diminish peripheral pain signaling and also produce central analgesic effects, while the antipyretic action results from resetting the hypothalamic temperature set‑point.

The appropriate dose of Nolotil is determined by the prescribing clinician based on the patient’s condition, age, weight, and renal function. Dosage regimens are individualized and should follow the prescriber’s instructions and local regulatory guidelines.

The safety of metamizole during pregnancy and lactation has not been firmly established, and it is generally classified as contraindicated or used only when the potential benefit outweighs the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To order Nolotil, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Metamizole provides analgesic and antipyretic effects similar to paracetamol but is often considered more potent for severe pain. Unlike many NSAIDs, it has minimal anti‑inflammatory activity and a lower risk of gastrointestinal irritation, but it carries a rare risk of agranulocytosis, which is not typical for paracetamol or standard NSAIDs.

Nolotil tablets should be stored at ambient temperature below 25 °C, in their original packaging, and protected from moisture and direct sunlight. Keep the product out of reach of children and avoid storing in damp or excessively hot environments.

Nolotil is administered orally, usually as a tablet that is swallowed whole with water. The exact method of administration, including whether it should be taken with food, is determined by the prescribing physician based on the individual treatment plan.

The most serious risk associated with Nolotil is agranulocytosis, a potentially life‑threatening drop in white blood cells. Patients should be monitored for signs of infection, such as fever or sore throat, and immediate medical attention is required if these symptoms appear.

Nolotil should be avoided in individuals with known hypersensitivity to metamizole or other pyrazolones, in patients with a history of agranulocytosis, and in children where safety has not been established. Caution is also advised for patients with severe renal or hepatic impairment.